The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Ynamide Click chemistry in development of triazole VEGFR2 TK modulators.EBI
University of Strasburg
Discovery of Potent Inhibitors of Schistosoma mansoni NAD¿ Catabolizing Enzyme.EBI
University of Strasburg
Selective nonpeptidic fluorescent ligands for oxytocin receptor: design, synthesis, and application to time-resolved FRET binding assay.EBI
University of Strasburg
Iminosugars as a new class of cholinesterase inhibitors.EBI
University of Strasburg
Catechol-rhodanine derivatives: Specific and promiscuous inhibitors of Escherichia coli deoxyxylulose phosphate reductoisomerase (DXR).EBI
University of Strasburg
Structure-activity relationship studies toward the discovery of selective apelin receptor agonists.EBI
University of Strasburg
Design, synthesis and biological evaluation of novel tetrahydroacridine pyridine- aldoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase.EBI
University of Strasburg
Synthesis and biological properties of thiazole-analogues of pyochelin, a siderophore of Pseudomonas aeruginosa.EBI
University of Strasburg
Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors.EBI
University of Strasburg
Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.EBI
University of Strasburg
Selective fluorescent nonpeptidic antagonists for vasopressin V2 GPCR: application to ligand screening and oligomerization assays.EBI
University of Strasburg
Methylation of imidazoline related compounds leads to loss ofa2-adrenoceptor affinity. Synthesis and biological evaluation of selective I1 imidazoline receptor ligands.EBI
University of Strasburg
Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents.EBI
University of Strasburg
Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.EBI
University of Strasburg
Reactive derivatives for affinity labeling in the ifenprodil site of NMDA receptors.EBI
University of Strasburg
New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam.EBI
University of Strasburg
Synthesis and biological evaluation of desmethylveramiline, a micromolar Hedgehog inhibitor.EBI
University of Strasburg
Flavonoids as inhibitors of human CD38.EBI
University of Strasburg
Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors.EBI
University of Strasburg
Heterocyclic bis-cations as starting hits for design of inhibitors of the bifunctional enzyme histidine-containing protein kinase/phosphatase from Bacillus subtilis.EBI
University of Strasburg
Tertiary amines for use in the treatment of cardiac disordersBDB
Universitetet I Oslo
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.BDB
University of Pennsylvania